Catalyst
Slingshot members are tracking this event:
Phase 3 data from first two trials of ALKS 5461 for Major depressive disorder due 1Q 2016
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ALKS |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 21, 2016
Occurred Source:
http://phx.corporate-ir.net/phoenix.zhtml?c=92211&p=irol-corporateNewsArticle&ID=2131031
Related Projects
Related Keywords
Alks 5461, Major Depressive Disorder, Core Efficacy Study, Data
